-
Benchmark Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)
来源: Buzz FX / 23 12月 2024 09:36:12 America/New_York
Benchmark Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND) Written by MarketBeat December 23, 2024 Share Link copied to clipboard. Ligand Pharmaceuticals ( NASDAQ:LGND - Get Free Report ) 's stock had its "buy" rating restated
Read more...